Login Register Cart 0
Research Article

IL1R2多态性与食管癌风险增加相关

卷 20, 期 5, 2020

页: [379 - 387] 页: 9

弟呕挨: 10.2174/1566524019666191025091204

价格: $65

conference banner
摘要

背景：食道癌（EC）是全球癌症死亡的第六大主要原因，总发病率正在上升。 目的：本研究旨在评估IL1R2单核苷酸多态性与中国人群EC风险之间的关系。 方法：使用Agena MassARRAY平台从384 EC和499对照中对IL1R2的6个SNP进行基因分型。多态性和EC风险之间的关联通过执行遗传模型和单元型分析进行评估。 结果：总体分析结果显示，rs11674595的等位基因C（比值[OR] = 1.42，95％置信区间[CI]：1.14-1.77，p = 0.002）和rs2072472的等位基因G（等位基因：OR = 1.35，95） ％CI：1.08-1.69，p = 0.008）与EC风险增加相关。在共显性，显性和加性模型下，发现rs11674595和rs2072472与EC风险相关。分层分析发现，rs11674595和rs2072472与男性和年龄大于55岁的亚组的EC风险增加相关。此外，Crs11674595Grs4851527单倍型与EC风险增加1.44倍显着相关（95％CI：1.12-1.84，p = 0.004）。 结论：我们的结果揭示了中国汉族人群IL1R2中SNPs（rs11674595和rs2072472）与EC风险之间的显着相关性。这些发现可能为预防和治疗乳糜泻提供有意义的参考。

关键词: 食管癌，IL1R2，多态性，病例对照研究，SNP，肿瘤发生。

« Previous Next »
[1]
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[2]
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66(2): 115-32.
[http://dx.doi.org/10.3322/caac.21338] [PMID: 26808342]
[3]
Mao WM, Zheng WH, Ling ZQ. Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev 2011; 12(10): 2461-6.
[PMID: 22320939]
[4]
Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol 2013; 19(34): 5598-606.
[http://dx.doi.org/10.3748/wjg.v19.i34.5598] [PMID: 24039351]
[5]
Geng TT, Xun XJ, Li S, et al. Association of colorectal cancer susceptibility variants with esophageal cancer in a Chinese population. World J Gastroenterol 2015; 21(22): 6898-904.
[http://dx.doi.org/10.3748/wjg.v21.i22.6898] [PMID: 26078566]
[6]
An J, Zhao J, Zhang X, et al. Impact of multiple Alcohol Dehydrogenase gene polymorphisms on risk of laryngeal, esophageal, gastric and colorectal cancers in Chinese Han population. Am J Cancer Res 2015; 5(8): 2508-15.
[PMID: 26396927]
[7]
Wu Y, Yan M, Li J, et al. Genetic polymorphisms in TERT are associated with increased risk of esophageal cancer. Oncotarget 2017; 8(6): 10523-30.
[http://dx.doi.org/10.18632/oncotarget.14451] [PMID: 28060765]
[8]
Wang J, Zhang B, Yang Z, et al. Association of gastrointestinal gland cancer susceptibility loci with esophageal carcinoma among the Chinese Han population: a case-control study. Tumour Biol 2016; 37(2): 1627-33.
[http://dx.doi.org/10.1007/s13277-015-3945-6] [PMID: 26304507]
[9]
Wang H, Yu J, Guo Y, et al. Genetic variants in the ZNF208 gene are associated with esophageal cancer in a Chinese Han population. Oncotarget 2016; 7(52): 86829-35.
[http://dx.doi.org/10.18632/oncotarget.13468] [PMID: 27907911]
[10]
Jia X, Liu P, Zhang M, et al. Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population. Int J Clin Exp Med 2015; 8(10): 19381-7.
[PMID: 26770579]
[11]
Abnet CC, Wang Z, Song X, et al. Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet 2012; 21(9): 2132-41.
[http://dx.doi.org/10.1093/hmg/dds029] [PMID: 22323360]
[12]
Wu C, Wang Z, Song X, et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat Genet 2014; 46(9): 1001-6.
[http://dx.doi.org/10.1038/ng.3064] [PMID: 25129146]
[13]
Gharahkhani P, Fitzgerald RC, Vaughan TL, et al. Genome-wide association studies in oesophageal adenocarcinoma and Barrett’s oesophagus: a large-scale meta-analysis. Lancet Oncol 2016; 17(10): 1363-73.
[http://dx.doi.org/10.1016/S1470-2045(16)30240-6] [PMID: 27527254]
[14]
Auron PE, Webb AC, Rosenwasser LJ, et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 1984; 81(24): 7907-11.
[http://dx.doi.org/10.1073/pnas.81.24.7907] [PMID: 6083565]
[15]
Apte RN, Dotan S, Elkabets M, et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 2006; 25(3): 387-408.
[http://dx.doi.org/10.1007/s10555-006-9004-4] [PMID: 17043764]
[16]
Mar AC, Chu CH, Lee HJ, et al. Interleukin-1 receptor type 2 acts with c-Fos to enhance the expression of interleukin-6 and vascular endothelial growth factor a in colon cancer cells and induce angiogenesis. J Biol Chem 2015; 290(36): 22212-24.
[http://dx.doi.org/10.1074/jbc.M115.644823] [PMID: 26209639]
[17]
Chun S, Kim H, Ku SY, Suh CS, Kim SH, Kim JG. The association between endometriosis and polymorphisms in the interleukin-1 family genes in Korean women. Am J Reprod Immunol 2012; 68(2): 154-63.
[http://dx.doi.org/10.1111/j.1600-0897.2012.01136.x] [PMID: 22509941]
[18]
Kamei H, Ishihara Y, Fuma D, et al. Interleukin-1 receptor gene variants are associated with aggressive periodontitis in the Japanese. Arch Oral Biol 2014; 59(7): 756-63.
[http://dx.doi.org/10.1016/j.archoralbio.2014.04.006] [PMID: 24818754]
[19]
Xia Y, Liu YQ, Chen K, Wang LC, Ma CY, Zhao YR. Association of IL-1R2 genetic polymorphisms with the susceptibility of ankylosing spondylitis in Northern Chinese Han population. Mod Rheumatol 2015; 25(6): 908-12.
[http://dx.doi.org/10.3109/14397595.2015.1024302] [PMID: 25736356]
[20]
Xie M, Zhang D, Zhang Y, et al. Association of genetic polymorphisms in IL-1R1 and IL-1R2 genes with IgA nephropathy in the Han Chinese population. Oncotarget 2017; 8(31): 50673-9.
[http://dx.doi.org/10.18632/oncotarget.16929] [PMID: 28881593]
[21]
Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc in Hum Gnet 2009; 60: 2-12.
[http://dx.doi.org/10.1002/0471142905.hg0212s60]
[22]
Peters VA, Joesting JJ, Freund GG. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav Immun 2013; 32(4): 1-8.
[http://dx.doi.org/10.1016/j.bbi.2012.11.006] [PMID: 23195532]
[23]
Re F, Sironi M, Muzio M, et al. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface “receptor” with anti-interleukin-1 function. J Exp Med 1996; 183(4): 1841-50.
[http://dx.doi.org/10.1084/jem.183.4.1841] [PMID: 8666940]
[24]
Sims JE, Dower SK. Interleukin-1 receptors. Eur Cytokine Netw 1994; 5(6): 539-46.
[PMID: 7727687]
[25]
Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 2012; 11(8): 633-52.
[http://dx.doi.org/10.1038/nrd3800] [PMID: 22850787]
[26]
Kondera-Anasz Z, Mielczarek-Palacz A, Switała J. [Significantly increased interleukin-1A and interleukin-1 soluble type II receptor levels in women with ovarian cancer]. Ginekol Pol 2003; 74(9): 761-6.
[PMID: 14674121]
[27]
Rückert F, Dawelbait G, Winter C, et al. Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis. PLoS One 2010; 5(8) e12243
[http://dx.doi.org/10.1371/journal.pone.0012243] [PMID: 20808857]
[28]
Lin R, Zhang C, Zheng J, et al. Chronic inflammation-associated genomic instability paves the way for human esophageal carcinogenesis. Oncotarget 2016; 7(17): 24564-71.
[http://dx.doi.org/10.18632/oncotarget.8356] [PMID: 27028857]
[29]
Na Y, Bai R, Zhao Z, Wang J, Wang Y, Zhang B, et al. IL1R2 polymorphisms and knee OA susceptibility in a Chinese Han population.
[30]
Zuo X, Li M, Yang Y, et al. Interleukin gene polymorphisms in Chinese Han population with breast cancer, a case-control study. Oncotarget 2017; 9(26): 17994-8001.
[PMID: 29719585]

Rights & Permissions Print Cite
Article Metrics
21
8
2
2
© 2024 Bentham Science Publishers | Privacy Policy